Bank Of Montreal Repare Therapeutics Inc. Transaction History

Bank Of Montreal

$191 Billion
Q1 2024

A detailed history of Bank Of Montreal transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Bank Of Montreal holds 105,262 shares of RPTX stock, worth $334,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares

105,262

Previous 104,962 0.29%

Holding current value

$334,733

Previous $766,000 35.38%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.53 - $8.41 $1,359 - $2,523	300 Added 0.29%	105,262 $495,000
Q4 2023 Feb 08, 2024	SELL	$3.22 - $11.79 $3,751 - $13,735	-1,165 Reduced 1.1%	104,962 $766,000
Q3 2023 Nov 01, 2023	SELL	$8.16 - $13.01 $95,447 - $152,177	-11,697 Reduced 9.93%	106,127 $1.28 Million
Q2 2023 Aug 02, 2023	SELL	$8.63 - $12.53 $94,955 - $137,867	-11,003 Reduced 8.54%	117,824 $1.25 Million
Q1 2023 Jun 13, 2024	BUY	$9.32 - $15.06 $210,305 - $339,828	22,565 Added 21.44%	127,827 $1.26 Million

Q4 2022 Feb 01, 2023	SELL	$12.5 - $18.13 $63,350 - $91,882	-5,068 Reduced 3.79%	128,827 $1.9 Million
Q3 2022 Nov 10, 2022	SELL	$11.57 - $15.59 $45,817 - $61,736	-3,960 Reduced 2.87%	133,895 $1.68 Million
Q2 2022 Aug 11, 2022	SELL	$8.45 - $14.84 $6,759 - $11,872	-800 Reduced 0.58%	137,855 $1.94 Million
Q1 2022 May 12, 2022	BUY	$11.38 - $21.88 $557 - $1,072	49 Added 0.04%	138,655 $2 Million
Q4 2021 Feb 11, 2022	SELL	$19.66 - $28.11 $288,648 - $412,711	-14,682 Reduced 9.58%	138,606 $3.04 Million
Q3 2021 Nov 12, 2021	SELL	$25.71 - $35.24 $1.19 Million - $1.62 Million	-46,100 Reduced 23.12%	153,288 $4.39 Million
Q2 2021 Aug 12, 2021	BUY	$30.1 - $34.85 $6 Million - $6.95 Million	199,388 New	199,388 $6.78 Million

Others Institutions Holding RPTX

# of Institutions

Shares Held

38.5M

Call Options Held

66.4K

Put Options Held

2.7K

View Full List

About Repare Therapeutics Inc.

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $133M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

More about RPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account